{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:21:51Z","timestamp":1783488111620,"version":"3.55.0"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.2169\/internalmedicine.5567-25","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:07:49Z","timestamp":1750874869000},"page":"290-296","source":"Crossref","is-referenced-by-count":1,"title":["Continuously High Titers of Multiple Islet-associated Autoantibodies in an Individual with an Elderly Onset of Type 1 Diabetes Mellitus and Basedow's Disease: A Case Report with a Review of Literature"],"prefix":"10.2169","volume":"65","author":[{"given":"Mana","family":"Ohnishi","sequence":"first","affiliation":[{"name":"Department of Diabetic Medicine, Kurashiki Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatoshi","family":"Anno","sequence":"additional","affiliation":[{"name":"Department of Diabetic Medicine, Kurashiki Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaio","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Diabetic Medicine, Kurashiki Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seizo","family":"Okauchi","sequence":"additional","affiliation":[{"name":"Department of Diabetic Medicine, Kurashiki Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Diabetic Medicine, Kurashiki Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kaku","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kaneto","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kamei","sequence":"additional","affiliation":[{"name":"Department of Diabetic Medicine, Kurashiki Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bingley PJ. Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 95: 25-33, 2010.","DOI":"10.1210\/jc.2009-1365"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem 57: 168-175, 2011.","DOI":"10.1373\/clinchem.2010.148205"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol 6: 270-277, 2010.","DOI":"10.1038\/nrendo.2010.40"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Huber A, Menconi F, Corathers S, et al. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 29: 697-725, 2008.","DOI":"10.1210\/er.2008-0015"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nakamura H, Usa T, Motomura M, et al. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. J Endocrinol Invest 31: 861-865, 2008.","DOI":"10.1007\/BF03346432"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Kawasaki E, Matsuura N, Eguchi K. Type 1 diabetes in Japan. Diabetologia 49: 828-836, 2006.","DOI":"10.1007\/s00125-006-0213-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Awata T, Kawasaki E, Tanaka S, et al. Association of type 1 diabetes with two Loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese. J Clin Endocrinol Metab 94: 231-235, 2009.","DOI":"10.1210\/jc.2008-0718"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kobayashi T, Tanaka S, Okubo M, et al. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metab 88: 4768-4775, 2003.","DOI":"10.1210\/jc.2002-021529"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Orban T, Sosenko JM, Cuthbertson D, et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 32: 2269-2274, 2009.","DOI":"10.2337\/dc09-0934"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bottazzo GF, Bosi E, Cull CA, et al. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia 48: 703-708, 2005.","DOI":"10.1007\/s00125-005-1691-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Borg H, Gotts\u00e4ter A, Landin-Olsson M, Fernlund P, et al. High levels of antigen-specific islet antibodies predict future\u03b2-cell failure in patients with onset of diabetes in adult age. J Clin Endocrinol Metab 86: 3032-3038, 2001.","DOI":"10.1210\/jc.86.7.3032"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wenzlau JM, Walter M, Gardner TJ, et al. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab 95: 4712-4719, 2010.","DOI":"10.1210\/jc.2010-0169"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Vaziri-Sani F, Oak S, Radtke J, et al. ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity 43: 598-606, 2010.","DOI":"10.3109\/08916930903555927"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mu\u00f1oz C, Floreen A, Garey C, et al. Misdiagnosis and diabetic ketoacidosis at diagnosis of type 1 diabetes: patient and caregiver perspectives. Clin Diabetes 37: 276-281, 2019.","DOI":"10.2337\/cd18-0088"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hawa MI, Kolb H, Schloot N, et al.; Action LADA consortium. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care 36: 908-913, 2013.","DOI":"10.2337\/dc12-0931"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wherrett DK, Chiang JL, Delamater AM, et al. Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report. Diabetes Care 38: 1975-1985, 2015.","DOI":"10.2337\/dc15-1429"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kawasaki E, Nakamura K, Kuriya G, et al. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes. J Clin Endocrinol Metab 95: 707-713, 2010.","DOI":"10.1210\/jc.2009-1733"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wyatt R, Williams AJ. Islet autoantibody analysis: radioimmunoassays. Methods Mol Biol 1433: 57-83, 2016.","DOI":"10.1007\/7651_2015_292"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Buzzetti R, Di Pietro S, Giaccari A, et al.; Non Insulin Requiring Autoimmune Diabetes Study Group. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30: 932-938, 2007.","DOI":"10.2337\/dc06-1696"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tiberti C, Giordano C, Locatelli M, et al. Identification of tyrosine phosphatase 2<sub> (256-760)<\/sub> construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. Diabetes 57: 1276-1283, 2008.","DOI":"10.2337\/db07-0874"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Isermann B, Ritzel R, Zorn M, et al. Autoantibodies in diabetes mellitus: current utility and perspectives. Exp Clin Endocrinol Diabetes 115: 483-490, 2007.","DOI":"10.1055\/s-2007-981452"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Schloot NC, Pham MN, Hawa MI, et al.; Action LADA Group. Inverse relationship between organ-specific autoantibodies and systemic immune mediators in type 1 diabetes and type 2 diabetes: Action LADA 11. Diabetes Care 39: 1932-1939, 2016.","DOI":"10.2337\/dc16-0293"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Long AE, Wilson IV, Becker DJ, et al. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study. Diabetologia 61: 1484-1490, 2018.","DOI":"10.1007\/s00125-018-4591-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kawasaki E, Kuriya G, Satoh T, et al. Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes. Ann N Y Acad Sci 1150: 248-521, 2008.","DOI":"10.1196\/annals.1447.027"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Kawasaki E, Kuriya G, Satoh T, et al. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86, 1994.","DOI":"10.2337\/diabetes.43.1.80"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Fleiner HF, Bj\u00f8ro T, Midthjell K, et al. Prevalence of thyroid dysfunction in autoimmune and type 2 diabetes: the population-based HUNT study in Norway. J Clin Endocrinol Metab 101: 669-677, 2016.","DOI":"10.1210\/jc.2015-3235"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Roh E, Kim YA, Ku EJ, et al. Two cases of methimazole-induced insulin autoimmune syndrome in graves&apos; disease. Endocrinol Metab (Seoul) 28: 55-60, 2013.","DOI":"10.3803\/EnM.2013.28.1.55"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kaneko K, Satake C, Izumi T, et al. Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report. BMC Endocr Disord 19: 5, 2019.","DOI":"10.1186\/s12902-018-0326-3"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Wang JP, Zhou ZG, Lin J, et al. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives. Tissue Antigens 70: 369-375, 2007.","DOI":"10.1111\/j.1399-0039.2007.00916.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Horie I, Kawasaki E, Ando T, et al. Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population. J Clin Endocrinol Metab 97: E1043-E1050, 2012.","DOI":"10.1210\/jc.2011-3109"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5567-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:33:56Z","timestamp":1768620836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5567-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5567-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"article-number":"5567-25"}}